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Abstract
Aims: primary pancreatic sarcomas represent an extremely rare histopathological entity accounting for less than
0.1% of all pancreatic malignancies. Pancreatic sarcomas tend to be more aggressive and have a poor prognosis.
Methods: the case of a 52 year old patient presenting with jaundice is presented and the available literature was
reviewed.
Results: primary pancreatic sarcomas are extremely rare. Pancreatic sarcomas are more aggressive than other
pancreatic neoplasms.
Conclusion: primary sarcomas of the pancreas are extremely rare, are aggressive and are associated with very poor
prognosis.
Background
Sarcomas represent a relatively rare malignant entity.
Primary sarcomas of the pancreas are even rarer.
Amongst pancreatic sarcomas, leiomyosarcomas have
been most commonly reported. A review of the litera-
ture reveals seven cases of carcinosarcoma. We report a
case of epitheloid carcinosarcoma in a young male
patient presenting with pancreatitis and jaundice.
Case presentation
A 52 year old male with a history of chronic alcohol
consumption was admitted in the medical department
of our community hospital with an acute onset of upper
abdominal pain, nausea and vomiting. The diagnostic
workup revealed elevated amylase and lipase of 1012U/l
and 1160U/l respectively. A swollen edematous pancreas
caput and gallbladder stones were evident on upper
abdominal ultrasound. At the time of admission, an
endoscopic retrograde cholangio-pancreaticography
(ERCP) was performed. The common bile duct however
could not be visualized. ERCP was repeated after three
days with papillotomy. A narrow common bile duct
without stones or stenosis was visualized [Figure 1].
The patient recovered fully and was discharged after
8 days. One month after discharge the patient was read-
mitted with right upper quadrant pain and jaundice.
The routine workup revealed elevated liver enzymes and
bilirubin (total bilirubin: 10.78 mg/dl, direct bilirubin
9.86 mg/dl, indirect bilirubin:0.92 mg/dl, alkaline phos-
phatase: 337.64U/l). Cholecystitis was evident on upper
abdominal sonography. Choledocholithiasis was present
on ERCP, papillotomy and stone extraction were
uneventful. Cholecystectomy was indicated.
Laparoscopic cholecystectomy was performed. During
laparoscopy the main bile duct appeared unusally wide
even after papillotomy and stone extraction, thus an
intraoperative cholangiography was performed. This
revealed a significant stenosis in the distal end of the cho-
ledochus. The proximal bile duct branches were dilated
(Figure 2). An ERCP on day two after cholecystectomy
showed a 2 × 3 cm measuring ulceration above the
papilla of Vateri [Figure 3]. Biopsies revealed an ulcerat-
ing malignoma with duodenal infiltration. A stent was
placed in the common bile duct. A CT scan of the abdo-
men revealed a large process of the pancreatic head with-
out signs of mesenteric vessels infiltration [Figure 4].
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enclosing the superior mesenteric and hepatic arteries with
mesenterial infiltration was identified, making a complete
resection unlikely. The tumor was left in situ and trans-
duodenal biopsies were taken for histopathology. With a
choledochus stent in place, a biliodigestive anastomosis was
not indicated. To prevent future bowel obstruction, a gas-
troenteric anastomosis was constructed using small bowel
40 cm distal to the ligament of Treitz. The postoperative
recovery was uneventful. A venous port system was
implanted 10 days after laparotomy. The patient was dis-
charged to our out-patient oncology. Chemotherapy with
Gencitabine, 5-Fluorouracil and Folinic acid was initiated.
Histopathology
Histologic sections revealed large neoplastic cells
with epitheloid and sarcomatoid differentiation.
Immunhistochemical staining demonstrated a co-
expression of cytokeratin and vimentin. Stains for Cal-
desmon, CD 34, CD 31 and S100 were negative. A
pure sarcoma or melanoma could be excluded on
immunhistochemistry [Figure 5 A-C].
Discussion
Sarcomas of the pancreas are exceedingly rare. Baylor et
al reported a 0.1% incidence of pancreatic sarcoma after
review 5000 cases of pancreatic cancer [1]. Amongst
pancreatic sarcomas leiomyosarcomas tend to occur
relatively frequent [2]. Epitheloid sarcomas also known
as carcinosarcomas represent an even rarer subgroup
with very few reported cases in the english literature.
Darvishian and colleagues reported the 7
th case in the
English literature [3]. Thus the incidence of carcinosar-
coma as a single entity is expected to be far below 0.1%.
Figure 1 ERCP at the initial presentation. (normal common bile
duct on ERCP at the initial presentation).
Figure 2 Intraoperative Cholangiogramm. (The thin arrow points
at the stenosis, while the thick arrow demonstrates central dilated
bile duct system).
Figure 3 Duodenal ulceration on ERCP. (the arrow points at a 2
× 3 cm ulceration in the duodenum on ERCP).
Figure 4 Ct scan of the pancreas. (The arrow marks the enlarged
pancreatic caput).
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occur frequently in younger individuals. The pancreatic
caput is most commonly involved followed by the tail
and the body [4]. These features tend to correspond
with those in the case presented. The patient, 52 years
of age, relatively young, was diagnosed with a sarcoma
of the pancreatic caput.
Clinically patients present with colicky pain, nausea
and vomiting. These findings are basically similar to
those of other pancreatic pathologies and are thus
unspecific to sarcomas. Gray and many others consider
a painless jaundice as a sign of an advanced lesion [5].
This was true for the case presented.
The diagnosis of pancreatic pathologies is usually con-
firmed using imaging techniques like ultrasound, com-
puted tomography (Ct), magnetic resonance imaging
(MRI), endoscopic retrograde cholangiopancreaticogrphy
(ERCP) [6-8].
On initial presentation abdominal ultrasound and
ERCP were not suspicious of a pancreatic malignancy as
seen in figure 1. A pancreatic process was suspected on
an intraoperative cholangiogramm as seen in figure 2.
This was later confirmed on CT and ERCP. To what
extend an early ct scan would have confirmed a malig-
nancy remains unclear.
Surgical resection is the only possible cure for pan-
creatic malignancies. Radical resections are done for
localized lesions. Advanced lesions warrant palliation.
Potts et al proved the importance of a palliative gastric
bypass in advanced stages [9].
In this case, the patient presented with an advanced
tumor, so curative resection was not feasible. A pallia-
tive gastroenteric anastomosis was done. The common
bile duct was not revised since a stent was placed during
ERCP [10]. A venous port system was implanted and the
patient was sent in for chemotherapy.
Pancreatic cancers generally have a poor prognosis
since they tend to be diagnosed in an advanced stage.
Sarcomas of the pancreas tend to grow much more
rapidly and are believed to be associated with an even
worse prognosis [4].
I nt h ec a s ep r e s e n t e d ,t h es a r c o m ac o u l dh a v eg r o w n
within three month, i.e between initial presentation in
November 2010 and diagnosis in January 2011. This
would support the notion that sarcomas tend to grow
rapidly. The patient was discharged from the surgical
department in a good shape and chemotherapy with
Gencitabine, 5- FU and folinic acid was initiated.
Conclusion
Primary sarcomas of the pancreas are extremely rare.
Although little is known about pancreatic sarcomas,
they appear to be more aggressive and are associated
with a worse prognosis.
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Figure 5 Histological slides. (HE, Cytokeratin and vemintin stains
showing tumor cells with little or no pancreatic tissue).
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